Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, Massachusetts
- Most recent report
- 8-K, filed Sep 14, 2026
- Incorporated
- Delaware
- Filings on record
- 580 filings
- On EDGAR
- CIK 1661998
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 35
News 8 of 69
Prospectuses and Registrations 8 of 45
- 424B3 Prospectus supplement for an offering Jul 28, 2026
- S-3 Shelf registration statement Jul 17, 2026
- 424B5 Prospectus supplement for an offering Jul 15, 2026
- 424B5 Prospectus supplement for an offering Jul 13, 2026
- S-3 Shelf registration statement Jun 25, 2026
- 424B5 Prospectus supplement for an offering Apr 24, 2026
- 424B5 Prospectus supplement for an offering Mar 27, 2026
- S-8 Registration statement for an employee plan Mar 10, 2026
Proxies 8 of 15
- DEFA14A Extra proxy material Apr 30, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2026
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- PRE 14A Preliminary proxy statement Apr 11, 2025
- DEFA14A Extra proxy material Apr 28, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2023
- DEFA14A Extra proxy material Apr 29, 2022
Ownership 8 of 353
- 4 Insider reported a trade Aug 27, 2026
- 4 Insider reported a trade Aug 27, 2026
- 4 Insider reported a trade Aug 27, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 31, 2026
- 4/A Insider reported a trade, amended Jul 21, 2026
- 4/A Insider reported a trade, amended Jul 21, 2026
Other 8 of 63
- EFFECT Notice that a registration became effective Jul 28, 2026
- EFFECT Notice that a registration became effective Jul 13, 2026
- ARS Annual report sent to shareholders Apr 30, 2026
- UPLOAD Comment letter from SEC staff Aug 28, 2025
- CORRESP Reply to SEC staff Aug 26, 2025
- CORRESP Reply to SEC staff Jul 31, 2025
- UPLOAD Comment letter from SEC staff Jul 30, 2025
- ARS Annual report sent to shareholders Apr 29, 2025
Everything here comes from Q32 Bio Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.